• Mashup Score: 0

    Volta Medical—a company that develops artificial intelligence (AI) solutions to assist electrophysiologists—has announced the appointment of Bill Hoffman as executive chairman of its board of directors. A press release states that Hoffman “brings a track record of guiding innovative startups to global success”. As former chief executive officer (CEO) of Inari Medical, Hoffman oversaw its growth from […]

    Tweet Tweets with this article
    • .@VoltaMedical, a company that develops artificial intelligence solutions to assist electrophysiologists, has announced the appointment of Bill Hoffman as executive chairman of its board of directors https://t.co/LvEEu1oOdT

  • Mashup Score: 0

    AtriCure has announced the first use of the newest AtriClip device for minimally invasive concomitant procedures, the AtriClip PRO-Mini left atrial appendage (LAA) exclusion system. The AtriClip PRO-Mini device received US Food and Drug Administration (FDA) 510(k) clearance earlier this year and builds upon the technology of the widely used AtriClip platform. The device is […]

    Tweet Tweets with this article
    • .@AtriCure has announced the first use of the newest AtriClip device for minimally invasive concomitant procedures, the AtriClip PRO-Mini left atrial appendage exclusion system https://t.co/YDvVjb2ThT

  • Mashup Score: 8

    A novel cardiac ablation system may hold the potential to improve upon the currently available treatments for ventricular arrhythmia (VA) patients, having demonstrated positive safety signals in a European registry study including more than 100 of these typically challenging cases. Safety data on this technology—the Affera mapping and ablation system (Medtronic), which offers the potential […]

    Tweet Tweets with this article
    • A novel cardiac ablation system may hold the potential to improve upon current ventricular arrhythmia treatments, having demonstrated positive safety signals in a European registry study including >100 cases @MDT_EPAblation @EHRAPresident @GerdHindricks https://t.co/cT097HxI3h

  • Mashup Score: 1

    Pacemaker implantation within 30 days after a transcatheter aortic valve implantation (TAVI) procedure has been found to correlate with significantly higher rates all-cause and cardiovascular-related mortality at up to 10 years of follow-up, as per data from the nationwide SwissTAVI registry. Late-breaking results from this registry were presented by Patrick Badertscher (University Hospital Basel, Basel, […]

    Tweet Tweets with this article
    • Pacemaker implantation within 30 days after a #TAVI procedure has been found to correlate with significantly higher all-cause and cardiovascular mortality rates at up to 10 years, as per SwissTAVI registry data @BadertscherPat @EHRAPresident @JACCJournals https://t.co/uhouR3Ou4z

  • Mashup Score: 12

    Johnson & Johnson (J&J) MedTech has today announced 12-month results from the SmartfIRE study, delivered as a late-breaking presentation at the ongoing European Heart Rhythm Association (EHRA) congress (30 March–1 April 2025, Vienna, Austria), with findings showing that use of the company’s dual-energy Thermocool Smarttouch SF catheter was 86.9% effective when patients were treated with […]

    Tweet Tweets with this article
    • .@JNJMedTech recently announced 12-month results from the SmartfIRE study showing that its dual-energy Thermocool Smarttouch SF catheter was 86.9% effective for treatments adhering to recommended ablation parameters @jjmt_ep @tomdepotter @EHRAPresident https://t.co/R5rRRLdcx7

  • Mashup Score: 0

    Conformal Medical has announced the enrolment of its 500th patient in the CONFORM investigational device exemption (IDE) trial, the prospective, multicentre, randomised controlled study evaluating the safety and efficacy of the Conformal CLAAS AcuFORM system compared to other commercially available left atrial appendage (LAA) devices. This marks a significant milestone in the, reaching close to […]

    Tweet Tweets with this article
    • .@conformalmed recently announced the enrolment of its 500th patient in the CONFORM IDE study, a prospective, multicentre RCT evaluating the safety and efficacy of the Conformal CLAAS AcuFORM system compared to other commercially available LAA devices https://t.co/aFAN3cJHuG

  • Mashup Score: 3

    New findings from the SINGLE SHOT CHAMPION trial, presented at the ongoing European Heart Rhythm Association (EHRA) congress (30 March–1 April 2025, Vienna, Austria) by Tobias Reichlin (Bern University Hospital, Bern, Switzerland), have shown the Farapulse pulsed field ablation (PFA) system (Boston Scientific) to be superior to the Arctic Front Advance cardiac cryoablation catheter (Medtronic) […]

    Tweet Tweets with this article
    • New findings from the SINGLE SHOT CHAMPION trial, presented at the 2025 @EHRAPresident congress, have indicated improved outcomes with @bostonsci's Farapulse PFA system vs @Medtronic's Arctic Front Advance cryoablation catheter in paroxysmal #AFib patients https://t.co/mt0HRlXFXt